federal_register: E8-2608
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E8-2608 | Oral Dosage Form New Animal Drugs; Phenylbutazone Tablets | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADAs) filed by IVX Animal Health, Inc. The supplemental NADAs provide revised labeling for phenylbutazone tablets used in horses and dogs. | 2008-02-13 | 2008 | 2 | https://www.federalregister.gov/documents/2008/02/13/E8-2608/oral-dosage-form-new-animal-drugs-phenylbutazone-tablets | https://www.govinfo.gov/content/pkg/FR-2008-02-13/pdf/E8-2608.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADAs) filed by IVX Animal Health, Inc. The supplemental NADAs provide revised labeling for... |